These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38198846)
1. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance. Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846 [TBL] [Abstract][Full Text] [Related]
2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900 [TBL] [Abstract][Full Text] [Related]
3. Emmanuel N; Li H; Chen J; Zhang Y Oncotarget; 2022 Oct; 13():1136-1139. PubMed ID: 36264074 [TBL] [Abstract][Full Text] [Related]
4. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma. Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648 [TBL] [Abstract][Full Text] [Related]
6. FSP1 is a glutathione-independent ferroptosis suppressor. Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899 [TBL] [Abstract][Full Text] [Related]
7. Gongying-Jiedu-Xiji recipe promotes the healing of venous ulcers by inhibiting ferroptosis via the CoQ-FSP1 axis. Lu Y; Zhao D; Liu M; Cao G; Liu C; Yin S; Song R; Ma J; Sun R; Wu Z; Liu J; Wang Y Front Pharmacol; 2023; 14():1291099. PubMed ID: 38161691 [No Abstract] [Full Text] [Related]
8. Curcumin Induces Ferroptosis in A549 CD133 Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092 [TBL] [Abstract][Full Text] [Related]
9. Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis. Pan X; Lin Z; Jiang D; Yu Y; Yang D; Zhou H; Zhan D; Liu S; Peng G; Chen Z; Yu Z Oncol Lett; 2019 Mar; 17(3):3001-3008. PubMed ID: 30854078 [TBL] [Abstract][Full Text] [Related]
10. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868 [TBL] [Abstract][Full Text] [Related]
11. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Zhang W; Dai J; Hou G; Liu H; Zheng S; Wang X; Lin Q; Zhang Y; Lu M; Gong Y; Xiang Z; Yu Y; Hu Y Mol Cell; 2023 Dec; 83(23):4352-4369.e8. PubMed ID: 38016474 [TBL] [Abstract][Full Text] [Related]
12. Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells. Gotorbe C; Durivault J; Meira W; Cassim S; Ždralević M; Pouysségur J; Vučetić M Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552620 [TBL] [Abstract][Full Text] [Related]
13. Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression. Tian RL; Wang TX; Huang ZX; Yang Z; Guan KL; Xiong Y; Wang P; Ye D J Mol Cell Biol; 2024 Sep; ():. PubMed ID: 39313331 [TBL] [Abstract][Full Text] [Related]
14. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer. Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990 [TBL] [Abstract][Full Text] [Related]
15. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer. Zhang Z; Ye B; Lin Y; Liu W; Deng J; Ji W Clin Transl Oncol; 2023 Nov; 25(11):3217-3229. PubMed ID: 37184781 [TBL] [Abstract][Full Text] [Related]
17. Identification of a Small Molecule That Enhances Ferroptosis via Inhibition of Ferroptosis Suppressor Protein 1 (FSP1). Yoshioka H; Kawamura T; Muroi M; Kondoh Y; Honda K; Kawatani M; Aono H; Waldmann H; Watanabe N; Osada H ACS Chem Biol; 2022 Feb; 17(2):483-491. PubMed ID: 35128925 [TBL] [Abstract][Full Text] [Related]
18. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications. Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H Apoptosis; 2024 Aug; 29(7-8):1019-1037. PubMed ID: 38615304 [TBL] [Abstract][Full Text] [Related]
19. Ferroptosis inhibitor alleviates sorafenib-induced cardiotoxicity by attenuating KLF11-mediated FSP1-dependent ferroptosis. Li Y; Yan J; Sun H; Liang Y; Zhao Q; Yu S; Zhang Y Int J Biol Sci; 2024; 20(7):2622-2639. PubMed ID: 38725840 [TBL] [Abstract][Full Text] [Related]
20. Ferroptosis model system by the re-expression of BACH1. Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]